217 related articles for article (PubMed ID: 23871820)
21. Structural insight into the role of Gln293Met mutation on the Peloruside A/Laulimalide association with αβ-tubulin from molecular dynamics simulations, binding free energy calculations and weak interactions analysis.
Zúñiga MA; Alderete JB; Jaña GA; Jiménez VA
J Comput Aided Mol Des; 2017 Jul; 31(7):643-652. PubMed ID: 28597356
[TBL] [Abstract][Full Text] [Related]
22. Electrostatic contributions to colchicine binding within tubulin isotypes.
Huzil JT; Barakat K; Tuszynski JA
Electromagn Biol Med; 2009; 28(4):355-64. PubMed ID: 20017626
[TBL] [Abstract][Full Text] [Related]
23. Computational design and biological testing of highly cytotoxic colchicine ring A modifications.
Torin Huzil J; Winter P; Johnson L; Weis AL; Bakos T; Banerjee A; Luduena RF; Damaraju S; Tuszynski JA
Chem Biol Drug Des; 2010 Jun; 75(6):541-50. PubMed ID: 20408852
[TBL] [Abstract][Full Text] [Related]
24. Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.
Buey RM; Calvo E; Barasoain I; Pineda O; Edler MC; Matesanz R; Cerezo G; Vanderwal CD; Day BW; Sorensen EJ; López JA; Andreu JM; Hamel E; Díaz JF
Nat Chem Biol; 2007 Feb; 3(2):117-25. PubMed ID: 17206139
[TBL] [Abstract][Full Text] [Related]
25. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
[TBL] [Abstract][Full Text] [Related]
26. Integration of ligand and structure-based virtual screening for the identification of the first dual targeting agent for heat shock protein 90 (Hsp90) and tubulin.
Knox AJ; Price T; Pawlak M; Golfis G; Flood CT; Fayne D; Williams DC; Meegan MJ; Lloyd DG
J Med Chem; 2009 Apr; 52(8):2177-80. PubMed ID: 19331414
[TBL] [Abstract][Full Text] [Related]
27. Differentiating between models of epothilone binding to microtubules using tubulin mutagenesis, cytotoxicity, and molecular modeling.
Entwistle RA; Rizk RS; Cheng DM; Lushington GH; Himes RH; Gupta ML
ChemMedChem; 2012 Sep; 7(9):1580-6. PubMed ID: 22807375
[TBL] [Abstract][Full Text] [Related]
28. Stabilization of microtubules by taxane diterpenoids: insight from docking and MD simulations.
Yadava U; Gupta H; Roychoudhury M
J Biol Phys; 2015 Mar; 41(2):117-33. PubMed ID: 25542396
[TBL] [Abstract][Full Text] [Related]
29. Structural comparison of the interaction of tubulin with various ligands affecting microtubule dynamics.
Stec-Martyna E; Ponassi M; Miele M; Parodi S; Felli L; Rosano C
Curr Cancer Drug Targets; 2012 Jul; 12(6):658-66. PubMed ID: 22385515
[TBL] [Abstract][Full Text] [Related]
30. 3D QSAR studies of the interaction between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA). A combined pharmacophore generation and pseudoreceptor modeling approach applied to taxanes and epothilones.
Manetti F; Forli S; Maccari L; Corelli F; Botta M
Farmaco; 2003 May; 58(5):357-61. PubMed ID: 12729829
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel antitubulin agents by using a virtual screening approach based on a 7-point pharmacophore model of the tubulin colchi-site.
Massarotti A; Theeramunkong S; Mesenzani O; Caldarelli A; Genazzani AA; Tron GC
Chem Biol Drug Des; 2011 Dec; 78(6):913-22. PubMed ID: 22039890
[TBL] [Abstract][Full Text] [Related]
33. Prediction of new chromene-based inhibitors of tubulin using structure-based virtual screening and molecular dynamics simulation methods.
Aryapour H; Dehdab M; Sohraby F; Bargahi A
Comput Biol Chem; 2017 Dec; 71():89-97. PubMed ID: 28992456
[TBL] [Abstract][Full Text] [Related]
34. 3D QSAR models of interactions between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA): a survey on taxanes and epothilones.
Manetti F; Maccari L; Corelli F; Botta M
Curr Top Med Chem; 2004; 4(2):203-17. PubMed ID: 14754454
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the covalent binding of N-phenyl-N'-(2-chloroethyl)ureas to {beta}-tubulin: importance of Glu198 in microtubule stability.
Fortin S; Bouchon B; Chambon C; Lacroix J; Moreau E; Chezal JM; Degoul F; C-Gaudreault R
J Pharmacol Exp Ther; 2011 Feb; 336(2):460-7. PubMed ID: 20978170
[TBL] [Abstract][Full Text] [Related]
36. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.
Giannakakou P; Gussio R; Nogales E; Downing KH; Zaharevitz D; Bollbuck B; Poy G; Sackett D; Nicolaou KC; Fojo T
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2904-9. PubMed ID: 10688884
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones.
Aryapour H; Riazi GH; Ahmadian S; Foroumadi A; Mahdavi M; Emami S
Pharm Biol; 2012 Dec; 50(12):1551-60. PubMed ID: 22984888
[TBL] [Abstract][Full Text] [Related]
38. Tools for the rational design of bivalent microtubule-targeting drugs.
Marangon J; Christodoulou MS; Casagrande FV; Tiana G; Dalla Via L; Aliverti A; Passarella D; Cappelletti G; Ricagno S
Biochem Biophys Res Commun; 2016 Oct; 479(1):48-53. PubMed ID: 27613098
[TBL] [Abstract][Full Text] [Related]
39. Indicine N-oxide binds to tubulin at a distinct site and inhibits the assembly of microtubules: a mechanism for its cytotoxic activity.
Appadurai P; Rathinasamy K
Toxicol Lett; 2014 Feb; 225(1):66-77. PubMed ID: 24300171
[TBL] [Abstract][Full Text] [Related]
40. Fragment based group QSAR and molecular dynamics mechanistic studies on arylthioindole derivatives targeting the α-β interfacial site of human tubulin.
Tyagi C; Gupta A; Goyal S; Dhanjal J; Grover A
BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S3. PubMed ID: 25521775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
